Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Current Issue

May 2022 (Vol. 42 Issue 5) Table of Contents
Anticancer Research: 42 (5)

Issue highlights

  • A Higher Mean Heart Radiation Dose Induces Higher Frequency of Multiple Cardiac Changes
  • Dimethyl Fumarate Induces Apoptosis via Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells
  • Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
  • Acute Side-effects of Different Radiotherapy Treatment Schedules in Early Prostate Cancer
  • The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer


Special Issue of ANTICANCER RESEARCH on NEW ANTICANCER AGENTS

Topics:

A. Experimental studies on “Νew Anticancer Agents”

1. Synthesis and evaluation in vitro and in vivo
2. Mechanism of action
3. Reversal of resistance to anticancer agents
4. Oncolytic viruses

B. Clinical studies on “New Anticancer Agents”

1. Pharmacology
2. Clinical trials
3. Combination chemotherapy
4. Immunotherapeutic agents
5. New methodologies in drug delivery
6. Vaccines

Publication date: March 2, 2023; Submission deadline: December 30, 2022

Instructions for the preparation and submission of reviews and original articles.


Special Issue of ANTICANCER RESEARCH on PROSTATE CANCER

Topics:

  • New diagnostic procedures
  • Genetic polymorphisms
  • Environmental and dietary risk factors
  • Chemoprevention
  • Treatment of early prostate cancer
  • Treatment of metastatic prostate cancer
  • Advances in surgical procedures
  • New drugs and drug combinations
  • Radiotherapy
  • Immunotherapy
  • Benign prostate hyperplasia

Publication date: January 5, 2023; Submission deadline: October 30, 2022

Instructions for the preparation and submission of reviews and original articles.


Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • Open Access
    Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes
    SIDDHARTH KUNTE, JONATHAN SHARETT, WEI WEI, CHRISTIAN NASR, BRANDON PRENDES, ERIC LAMARRE, JAMIE KU, ROBERT R. LORENZ, JOSEPH SCHARPF, BRIAN B. BURKEY, AKEESHA SHAH, NIKHIL JOSHI and JESSICA L. GEIGER
    Anticancer Research May 2022, 42 (5) 2531-2539; DOI: https://doi.org/10.21873/anticanres.15731
  • You have access
    Copenhagen Rats Display Dominantly Inherited Yet Non-uniform Resistance to Spontaneous, Radiation-induced, and Chemically-induced Mammary Carcinogenesis
    MAYUMI NISHIMURA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, YUKIKO NISHIMURA, TOSHIAKI KOKUBO, MASARU TAKABATAKE, SHIZUKO KAKINUMA and YOSHIYA SHIMADA
    Anticancer Research May 2022, 42 (5) 2415-2423; DOI: https://doi.org/10.21873/anticanres.15720
  • You have access
    Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma
    MICHAEL H. WANG, WILSON ROA, KEITH WACHOWICZ, ATIYAH YAHYA, ALBERT MURTHA, JOHN AMANIE, JONATHAN CHAINEY, HARVEY QUON, SUNITA GHOSH and SAMIR PATEL
    Anticancer Research May 2022, 42 (5) 2665-2673; DOI: https://doi.org/10.21873/anticanres.15744
  • Open Access
    Guanylate-binding Protein 2 Expression Is Associated With Poor Survival and Malignancy in Clear-cell Renal Cell Carcinoma
    QINGYUAN LIU, ROBERT M. HOFFMAN, JING SONG, SHIQI MIAO, JINDONG ZHANG, DEGANG DING and DELIN WANG
    Anticancer Research May 2022, 42 (5) 2341-2354; DOI: https://doi.org/10.21873/anticanres.15713
  • You have access
    Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor
    KOSEI TAKAGI, YUZO UMEDA, RYUICHI YOSHIDA, KAZUHIRO YOSHIDA, TOMOKAZU FUJI, KENJIRO KUMANO, KAZUYA YASUI, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA
    Anticancer Research May 2022, 42 (5) 2797-2801; DOI: https://doi.org/10.21873/anticanres.15760
  • Open Access
    Dynamic Integrated Backscatter Detects Radiotherapy-induced Cardiac Changes Better than Strain Analysis – A Prospective Three-year Study
    SUVI SIRKKU TUOHINEN, TANJA SKYTTA, HEINI HUHTALA, VESA VIRTANEN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and PEKKA RAATIKAINEN
    Anticancer Research May 2022, 42 (5) 2507-2517; DOI: https://doi.org/10.21873/anticanres.15729
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire